Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KAL1 |
| Upstream (Parents) |
|---|
| (<<) FSTL1 → KAL1 |
| (<<) VIM → KAL1 |
| (<<) COL1A1 → KAL1 |
| (<<) VCAN → KAL1 |
| (<<) OLFML2B → KAL1 |
| Downstream (Children) |
|---|
| KAL1 → SLCO2A1 (>>) |
| KAL1 → RASL12 (>>) |
| KAL1 → UCHL1 (>>) |
| KAL1 → INSRR (>>) |
| KAL1 → MATN3 (>>) |
| KAL1 → SCG2 (>>) |
| KAL1 → EGFL6 (>>) |
| KAL1 → TEX14 (>>) |
| KAL1 → FAM155A (>>) |
| KAL1 → PDZRN4 (>>) |
| KAL1 → IKZF2 (>>) |
| KAL1 → BNC2 (>>) |
| KAL1 → CST2 (>>) |
| KAL1 → KIT (>>) |
| KAL1 → CDKL5 (>>) |
| KAL1 → OLFML2B (>>) |
